345 related articles for article (PubMed ID: 4369538)
1. [Difficulties of remission induction treatment of acute myeloblastic leukemia].
Fière D; Bryon PA; Martin C; Revol L
Sem Hop; 1974 May; 50(25):1691-4. PubMed ID: 4369538
[No Abstract] [Full Text] [Related]
2. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
Malpas J; Mathé G; Hayat M
Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
[No Abstract] [Full Text] [Related]
3. [Treatment of acute myelogenous leukemia in adults; an account of the years 1968 to 1975].
Willemze R; den Ottolander GJ; Heering KJ; Brand A; Zwaan FE; Haak HL; Hartgrink-Groeneveld CA; Jansen J; Eernisse JG
Ned Tijdschr Geneeskd; 1977 Nov; 121(46):1843-7. PubMed ID: 270615
[No Abstract] [Full Text] [Related]
4. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine].
Büchner T; Kamanabroo D; Hiddemann W; Urbanitz D
Verh Dtsch Ges Inn Med; 1978; (84):145-8. PubMed ID: 283634
[No Abstract] [Full Text] [Related]
6. [Quality of survival in patients with acute leukemia subjected to combination drug therapy].
Almici C; Inzoli MR
G Clin Med; 1976; 57(5-6):183-91. PubMed ID: 1070454
[No Abstract] [Full Text] [Related]
7. Absence of the influence of age on remission rate and duration of remission in a group of thirty-four patients with acute myeloid leukaemia.
De Vries EG; Mulder NH; Houwen B; Haaxma-Reiche H; De Vries-Hospers HG
Neth J Med; 1980; 23(6):241-5. PubMed ID: 6936611
[No Abstract] [Full Text] [Related]
8. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790
[No Abstract] [Full Text] [Related]
9. Prognosis of acute leukaemia in adults.
Penington DG; Keating MJ
Med J Aust; 1974 Jun; 1(26):1031-5. PubMed ID: 4527947
[No Abstract] [Full Text] [Related]
10. Treatment of acute leukemia in adults. Results with a combination of potent cytotoxic drugs.
Stavem P; Gjemdal T
Acta Med Scand; 1974; 196(1-2):121-5. PubMed ID: 4529548
[No Abstract] [Full Text] [Related]
11. [Therapy of non-lymphoid acute leukemias].
Mandelli F
Minerva Med; 1975 Jul; 66(51):1546-52. PubMed ID: 1057048
[No Abstract] [Full Text] [Related]
12. [Treatment of acute myeloblastic leukemia. 79 cases treated by cytosine-rubidomycin combination].
Brun B; Rochant H; Gluckman E; Reyes F; Dreyfus B
Nouv Presse Med; 1974 Feb; 3(6):291-4. PubMed ID: 4522835
[No Abstract] [Full Text] [Related]
13. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of acute myeloid leukemia in the young and adult with aracytin and thioguanine].
Gansl RC; Cabral E; Gomes Filho JM; Silveira PA; Gualandro SF; Zanichelli MA; Pozzi D
Rev Hosp Clin Fac Med Sao Paulo; 1979; 34(5):207-10. PubMed ID: 297263
[No Abstract] [Full Text] [Related]
15. [Experiences in the treatment of acute myeloblastic leukemia and acute monocytic leukemia using cytosine arabinoside and 6-thioguanine].
Essers U; Althof S; Ewers M
Verh Dtsch Ges Inn Med; 1975; 81():1126-8. PubMed ID: 1065154
[No Abstract] [Full Text] [Related]
16. [Therapy of adult myeloblastic leukemia in complete remission with modified TRAP, COAP and POMP cycles].
Fülle HH
Verh Dtsch Ges Inn Med; 1978; (84):148-51. PubMed ID: 283635
[No Abstract] [Full Text] [Related]
17. [Treatment of acute myeloblastic leukemia with daunorubicin and cytosine-arabinoside].
Thorling K; Petersen HS; Jensen KB; Bastrup-Madsen P
Ugeskr Laeger; 1972 Oct; 134(42):2201-5. PubMed ID: 4507751
[No Abstract] [Full Text] [Related]
18. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
[No Abstract] [Full Text] [Related]
19. [Combination chemotherapy of acute myeloblastic leukemias (author's transl)].
Bauters F; Mouton J; Carrez J; Goudemand M
Nouv Rev Fr Hematol; 1974; 14(5):653-62. PubMed ID: 4281478
[No Abstract] [Full Text] [Related]
20. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia.
Carey RW; Ribas-Mundo M; Ellison RR; Glidewell O; Lee ST; Cuttner J; Levy RN; Silver R; Blom J; Haurani F; Spurr CL; Harley JB; Kyle R; Moon JH; Eagan RT; Holland JH
Cancer; 1975 Nov; 36(5):1560-6. PubMed ID: 1059499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
